Veterinary medicinal product register

The FVS registers website is using cookies. By continuing using this website you are agreeing to use cookies. Agree Cookies policy
Data selected by 2057 Name Nobivac RL
Original name Strength Marketing authorisation number Marketing authorisation holder: ATCvet code Species More
Nobivac RL - V/NRP/96/0379 Intervet International B.V., Nīderlande QI07AL01 dogs Vairāk

Medicinal product information

Pharmaceutical form: suspension for injection
International name (active substance): Inactivated rabies virus strain Pasteur RIV, Leptospira interrogans, serogroup Canicola, serovar Portland-vere, strain Ca-12-000, Inactivated, Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Copenhageni, strain 820K, Inactivated
Distribution category: To be used only by veterinary surgeon
Manufacturer(s) responsible for batch release Intervet International Booxmer, Nīderlande
Date of authorisation/renewal: 16-Nov-2010
Marketing authorisation valid until: Unlimited time period
Marketing authorisation procedure: NRP
Package leaflet: [DOCX] 280621LI (28-Jun-2021)
Labelling text: [DOCX] 280621M (28-Jun-2021)
Summary of product characteristics: [DOCX] 280621ZA (28-Jun-2021)

Products

ID Strength Package size Primary packaging Labelling
V/NRP/96/0379-01 10 Stikla flakons (kartona kastē), 1 deva -
V/NRP/96/0379-03 10 Stikla flakons (plastmasas kastē), 1 deva -
Nobivac RL - V/I/25/0007 Intervet International B.V., Nīderlande QI07AL01 dogs

Medicinal product information

Pharmaceutical form: suspension for injection
International name (active substance): Inactivated rabies virus strain Pasteur RIV, Leptospira interrogans, serogroup Canicola, serovar Portland-vere, strain Ca-12-000, Inactivated, Leptospira interrogans, serogroup Icterohaemorrhagiae, serovar Copenhageni, strain 820K, Inactivated
Distribution category: To be used only by veterinary surgeon
Manufacturer(s) responsible for batch release Intervet International Booxmer, Nīderlande
Date of authorisation/renewal: 19-Mar-2025
Marketing authorisation valid until: 18-Mar-2030
Marketing authorisation procedure: I
Package leaflet: [DOCX] 19032025LI (19-Mar-2025)
Labelling text: See products section
Summary of product characteristics: -

Products

ID Strength Package size Primary packaging Labelling
V/I/25/0007-01 10 Stikla flakons, 1 deva [PDF]

2 records · Download

  • 1